BayCare Central Pharmacy is recalling 1,157 bags of Norepinephrine bitartrate (16 mg in 250 mL NaCl 0.9%) intravenous (IV) solution. This prescription medication is being recalled because it was found to be subpotent, meaning the drug is weaker than intended. The recall affects six specific lots distributed to healthcare facilities in Florida with expiration dates of March 31, 2022.
If a patient receives a subpotent dose of norepinephrine, it may fail to adequately increase their blood pressure during a critical medical event, potentially leading to serious health consequences. No incidents or injuries have been reported to date.
Quantity: 1157 bags total.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.